Procter & Gamble Company (The) $PG Shares Sold by Maple Capital Management Inc.

Maple Capital Management Inc. cut its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 4.0% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 11,788 shares of the company’s stock after selling 490 shares during the quarter. Maple Capital Management Inc.’s holdings in Procter & Gamble were worth $2,009,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Northern Trust Corp raised its holdings in Procter & Gamble by 0.8% during the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock worth $5,051,930,000 after purchasing an additional 248,792 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in Procter & Gamble by 3.5% during the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock worth $2,966,252,000 after purchasing an additional 583,629 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock worth $2,947,146,000 after buying an additional 1,018,865 shares in the last quarter. Finally, Royal Bank of Canada increased its position in Procter & Gamble by 0.6% during the first quarter. Royal Bank of Canada now owns 17,273,679 shares of the company’s stock worth $2,943,779,000 after buying an additional 111,162 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Procter & Gamble news, CEO Jennifer L. Davis sold 8,596 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,351,892.92. Following the completion of the sale, the chief executive officer owned 64,991 shares of the company’s stock, valued at approximately $10,221,134.57. The trade was a 11.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Sundar G. Raman sold 9,554 shares of the business’s stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,511,060.64. Following the sale, the chief executive officer directly owned 41,886 shares of the company’s stock, valued at approximately $6,624,689.76. This trade represents a 18.57% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 120,181 shares of company stock valued at $18,918,012 in the last 90 days. 0.20% of the stock is owned by corporate insiders.

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $158.63 on Friday. The company has a market cap of $371.27 billion, a P/E ratio of 24.37, a P/E/G ratio of 4.15 and a beta of 0.36. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 52 week low of $149.91 and a 52 week high of $180.43. The business has a fifty day simple moving average of $156.26 and a 200-day simple moving average of $162.00.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter in the previous year, the business earned $1.40 earnings per share. The business’s revenue for the quarter was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were given a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble’s payout ratio is 64.82%.

Analysts Set New Price Targets

Several equities analysts have weighed in on PG shares. Wells Fargo & Company dropped their price target on Procter & Gamble from $175.00 to $173.00 and set an “overweight” rating for the company in a research report on Wednesday, July 30th. Evercore ISI reissued an “in-line” rating and set a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. BNP Paribas reissued an “outperform” rating and set a $177.00 price target on shares of Procter & Gamble in a research report on Friday, August 15th. UBS Group set a $180.00 price target on Procter & Gamble and gave the stock a “buy” rating in a research report on Wednesday, July 30th. Finally, Barclays set a $164.00 price target on Procter & Gamble and gave the stock an “equal weight” rating in a research report on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $175.12.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.